SCHEMBL19863881

SCHEMBL19863881

C1=Cc2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2C2(c3ccccc31)c1ccccc1-c1ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.41
▸ KMT2A Q03164 6/20 0.41
▸ MAPT P10636 5/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ HPGD P15428 3/20 0.41
▸ NTSR1 P30989 1/20 0.37
▸ LMNA P02545 4/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ GLA P06280 2/20 0.36
▸ PDK2 Q15119 3/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ADORA2A P29274 3/20 0.35
▸ ADORA1 P30542 3/20 0.35
▸ ADORA3 P0DMS8 2/20 0.34
▸ ADORA2B P29275 2/20 0.34
▸ POLB P06746 2/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19863873 0.99 MEN1 (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19863960 0.97 MEN1 (0.42) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19863865 0.96 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19863878 0.95 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19863904 0.95 PDK2 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19863870 0.95 PDK2 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19863823 0.94 MEN1 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19863886 0.93 PDK2 (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19863900 0.93 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19863809 0.93 PDK2 (0.40) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10476006-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-11-12 — — US disclosed
EP-3281936-B1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME SHANGHAI NICHEM FINE CHEMICAL CO LTD (CN) 2019-10-09 — — EP disclosed
US-20180047908-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-15 — — US disclosed
US-20180047908-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-15 — — US disclosed
EP-3281936-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME Nichem Fine Technology Co., Ltd. (TW) 2018-02-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10476006-B2 Compound and organic electronic device using the same ESR1, AOC2, PIEZO1 MEN1 205/4885KMT2A 844/4885MAPT 4225/4885
US-20180047908-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME ESR1, AOC2, PIEZO1 MEN1 205/4885KMT2A 844/4885MAPT 4225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback